FOXP3 and arthritic joint disease: The co-administration of heptanoyl CoA (a competitive inhibitor of butyrate synthase) confirmed the contribution of madecassoside-induced butyrate to the anti-arthritis action, as it caused the downregulation of ileum Treg cell number and expression of Foxp3 and IL-10 [113].